University of Texas: Osteosarcoma Profiling Reveals Why Immunotherapy Remains Ineffective
February 22, 2020
February 22, 2020
HOUSTON, Texas, Feb. 22 [TNSmedicalresearch] -- The University of Texas's MD Anderson Cancer Center issued the following news release on Feb. 21:
* * *
- Study points to strategies for improving outcomes with immunotherapy in rare cancer type
* * *
Comprehensive profiling of tumor samples taken from patients with osteosarcoma shows that multiple factors contribute to the traditionally poor responses observed from treatment with immune checkpoin . . .
* * *
- Study points to strategies for improving outcomes with immunotherapy in rare cancer type
* * *
Comprehensive profiling of tumor samples taken from patients with osteosarcoma shows that multiple factors contribute to the traditionally poor responses observed from treatment with immune checkpoin . . .